Evaluation of Seralutinib Treatment Effect Across Four Risk Tools in the TORREY Study in Pulmonary Arterial Hypertension (PAH) - Research portal of Justus Liebig University Giessen:

Meeting Abstract

Evaluation of Seralutinib Treatment Effect Across Four Risk Tools in the TORREY Study in Pulmonary Arterial Hypertension (PAH)

Authors list: Benza, R. L.; Osterhout, R.; Hoffman, S.; Zamanian, R. T.; Hemnes, A. R.; Channick, R. N.; Chin, K. M.; Frantz, R. P.; Ghofrani, A.; Howard, L. S.; McLaughlin, V. V.; Vachiery, J.; Zisman, L. S.; Cravets, M.; Bruey, J.; Roscigno, R. F.; Mottola, D.; Aranda, R.; Sitbon, O.

Publication year: 2024

Pages: S86-S87

Journal: The Journal of Heart and Lung Transplantation

Volume number: 43

Issue number: 4

ISSN: 1053-2498

eISSN: 1557-3117

Conference: 44th Annual Meeting and Scientific Sessions Conference of the International-Society-for-Heart-and-Lung-Transplantation (ISHLT)

Publisher: Elsevier

Citation Styles

Harvard Citation style: Benza, R., Osterhout, R., Hoffman, S., Zamanian, R., Hemnes, A., Channick, R., et al. (2024) Evaluation of Seralutinib Treatment Effect Across Four Risk Tools in the TORREY Study in Pulmonary Arterial Hypertension (PAH), The Journal of Heart and Lung Transplantation, 43(4), pp. S86-S87

APA Citation style: Benza, R., Osterhout, R., Hoffman, S., Zamanian, R., Hemnes, A., Channick, R., Chin, K., Frantz, R., Ghofrani, A., Howard, L., McLaughlin, V., Vachiery, J., Zisman, L., Cravets, M., Bruey, J., Roscigno, R., Mottola, D., Aranda, R., & Sitbon, O. (2024). Evaluation of Seralutinib Treatment Effect Across Four Risk Tools in the TORREY Study in Pulmonary Arterial Hypertension (PAH). The Journal of Heart and Lung Transplantation. 43(4), S86-S87.